[
    [
        {
            "time": "2018-04-16",
            "original_text": "广发证券：陆股通北上资金再度加速",
            "features": {
                "keywords": [
                    "陆股通",
                    "北上资金",
                    "加速"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "广发证券：陆股通北上资金再度加速",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-04-17",
            "original_text": "极具成长空间 5股现黄金买点",
            "features": {
                "keywords": [
                    "成长空间",
                    "黄金买点"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "极具成长空间 5股现黄金买点",
                "Correlation": 6,
                "Sentiment": 9,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 4,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-04-18",
            "original_text": "[增持评级]医药生物行业周报：紧握高景气主线 注重估值匹配性",
            "features": {
                "keywords": [
                    "医药生物",
                    "高景气",
                    "估值匹配性"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[增持评级]医药生物行业周报：紧握高景气主线 注重估值匹配性",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-04-19",
            "original_text": "东吴医药行业周观点：重点推荐医药细分领域业绩显著向上的OTC板块 建议关注片仔癀、济川药业、葵花药业等",
            "features": {
                "keywords": [
                    "医药",
                    "OTC板块",
                    "业绩显著向上",
                    "片仔癀",
                    "济川药业",
                    "葵花药业"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "东吴医药行业周观点：重点推荐医药细分领域业绩显著向上的OTC板块 建议关注片仔癀、济川药业、葵花药业等",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-04-20",
            "original_text": "首只“独角兽”新股申购，药明康德中一签或能赚4万！",
            "features": {
                "keywords": [
                    "独角兽",
                    "新股申购",
                    "药明康德"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "首只“独角兽”新股申购，药明康德中一签或能赚4万！",
                "Correlation": 9,
                "Sentiment": 10,
                "Importance": 9,
                "Impact": 9,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 10,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-04-21",
            "original_text": "救命新政颁布！进口抗癌药将实现零关税，这四只龙头概念可关注",
            "features": {
                "keywords": [
                    "新政",
                    "抗癌药",
                    "零关税",
                    "龙头概念"
                ],
                "sentiment_score": 0.95,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "救命新政颁布！进口抗癌药将实现零关税，这四只龙头概念可关注",
                "Correlation": 8,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 10,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-04-22",
            "original_text": "抗癌药进口关税将降为零 国内创新龙头受益",
            "features": {
                "keywords": [
                    "抗癌药",
                    "进口关税",
                    "国内创新龙头"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "抗癌药进口关税将降为零 国内创新龙头受益",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-04-23",
            "original_text": "中金：公募基金价值蓝筹股持仓比例高位回落",
            "features": {
                "keywords": [
                    "公募基金",
                    "价值蓝筹股",
                    "持仓比例",
                    "高位回落"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "中金：公募基金价值蓝筹股持仓比例高位回落",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-04-24",
            "original_text": "基金1Q持仓分析(医疗保健行业)：1Q资金配置同比提升 聚焦长期逻辑通顺标的",
            "features": {
                "keywords": [
                    "基金",
                    "医疗保健",
                    "资金配置",
                    "同比提升",
                    "长期逻辑通顺"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "基金1Q持仓分析(医疗保健行业)：1Q资金配置同比提升 聚焦长期逻辑通顺标的",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-04-25",
            "original_text": "首只IPO独角兽今申购 药明康德中一签或至少获利4万",
            "features": {
                "keywords": [
                    "IPO",
                    "独角兽",
                    "药明康德",
                    "获利"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "首只IPO独角兽今申购 药明康德中一签或至少获利4万",
                "Correlation": 9,
                "Sentiment": 10,
                "Importance": 9,
                "Impact": 9,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-04-26",
            "original_text": "股票型和混合型基金一季度均亏损",
            "features": {
                "keywords": [
                    "股票型",
                    "混合型基金",
                    "一季度",
                    "亏损"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "股票型和混合型基金一季度均亏损",
                "Correlation": 6,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 10,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-04-27",
            "original_text": "恒瑞医药加码研发 “A股药王”创新不易",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "加码研发",
                    "A股药王",
                    "创新不易"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "恒瑞医药加码研发 “A股药王”创新不易",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]